European Apheresis Devices Research Report
- Report Code: AP 1003
- Publish Date: Upcoming
The European market for apheresis devices is mainly driven by increasing prevalence of blood disorders such as bleeding problems and platelet disorders. In addition, the growing prevalence of chronic diseases such as cancer and autoimmune diseases, supply of platelets owing to an increasing number of platelet donors, improvement in healthcare infrastructure and facilities, and demand for plasma by biopharmaceutical companies will aid the growth of the market.
The report on the European apheresis device market segments the market by applications, procedures, and technologies. On the basis of applications, the market is segmented into renal diseases, hematology, and neurology. By procedures, the market is divided into plasmapheresis, LDL-apheresis, plateletpheresis, leukapheresis, photopheresis, and erythrocytapheresis. By technology, the market is classified into membrane filtration and centrifugation. Geographically, the market is segmented into U.K., Germany, France, Italy, Spain, and Rest of Europe.
This report also provides an extensive competitive landscape of companies operating in this market. Asahi Kasei Kuraray Medical Co., Ltd., Terumo BCT, Inc., Haemonetics Corporation, Kawasumi Laboratories, Inc., HemaCare Corporation, and Fenwal Inc. In addition to this, the report also provides insights about the apheresis devices industry along with burning issues in this market, such as refurbishment cuts. Segment and country-specific company shares, news and deals, mergers and acquisitions, segment-specific pipeline products, product approvals, and product recalls of major companies have been detailed in the report.
Report Customization Options
Along with market data, you can also customize MMM offerings that are in keeping with your company’s specific needs. Customize your report on the European market for apheresis devices to get an insight into all-inclusive industry standards and a deep-dive analysis of the following considerations:
Product Analysis
- Usage pattern (in-depth trend analysis) of products (segment wise)
- Product matrix which gives a detailed comparison of the product portfolio of each company mapped at country and sub-segment level
- End-user adoption rate analysis of the products (segment wise and country wise)
- Comprehensive coverage of product approvals, pipeline products, and product recalls
Epidemiology Data
- Market share by product type and region
- Country-specific patient pool of cancer and blood disorders
- Disease progression (pattern analysis)
- Distribution channels
Procedure Volume Data
- Number of apheresis device units installed in various regions
- Number of apheresis procedures
Surgeon/Physician Perception Analysis
- Fast turnaround analysis of surgeons’ response to market events and trends
- Surgeons’ opinions about products from different companies
- Surgeons’ qualitative inputs on epidemiology data
Brand/Product Perception Matrix
- Comprehensive study of customer perception and behavior through our inbuilt social connect tool checking the virality and tonality of blogs
- Analysis of overall brand usage and familiarity and brand advocacy distribution (detractor/neutral/familiar)
Alternative Products: Impact analysis
MMM’s Healthcare Decision-Making Quadrant: It is an innovative and useful quadrant for vendors who wish to analyze potential growth markets based on parameters like patient dynamics (patient pool, epidemiology of disease, preference towards surgeries/alternative therapies) and macroeconomic indicators (number of hospitals and orthopedic clinics, reimbursement scenario, diagnosis rate, treatment rate, and healthcare expenditure).
1 Introduction
1.1 Objective of the study
1.2 Market Definitions
1.3 Market Segmentation & Aspects Covered
1.4 Research Methodology
1.4.1 Assumptions (Market Size, Forecast, etc)
2 Executive Summary
3 Market Overview
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
| PRODUCT TITLE | PUBLISHED | |
|---|---|---|
|
|
North American Apheresis Market The North American Apheresis market was valued at $641.71 million in 2013 and is expected to reach $1062.59 million by 2018 growing at a CAGR of 10.6% from 2013 to 2018. Apheresis market can be segmented by By Procedure: Donor Apheresis and Therapeutic Apheresis (Neurologic Disorders, Blood Disorders (TTP, Leukemia, & Others), Renal Disease , Metabolic Disorders, Others (Rheumatic disorders, Malaria, Hyperviscosity syndrome, & others) By Application: (Plasmapheresis, Plateletpheresis Erythrocytapheresis, Leukoreduction/leukapheresis, Others (photopheresis, lipidpheresis, and Immunoadsoption) By Technology: Centrifugation and Membrane Separation/Filtration By Product type: Devices and Disposables By End-user: Blood banks/Blood collection centers, Hospitals & Hospital attached blood banks and Others The key players in the market are Haemonetics Corporation (U.S.), FRESENIUS MEDICAL CARE (Germany),& Terumo BCT, Inc. (U.S.), Asahi Kasei Medical Co., Ltd. (Japan), Kawasumi Laboratories Inc (Japan), and HemaCare Corporation (U.S.), with Haemonetics leading the pack. |
Upcoming |
|
|
European Apheresis Market The European Apheresis market was valued at $6366.89 million in 2013 and is expected to reach $596.13 million by 2018 growing at a CAGR of 10.2% from 2013 to 2018. Apheresis market can be segmented by By Procedure: Donor Apheresis and Therapeutic Apheresis (Neurologic Disorders, Blood Disorders (TTP, Leukemia, & Others), Renal Disease , Metabolic Disorders, Others (Rheumatic disorders, Malaria, Hyperviscosity syndrome, & others) By Application: (Plasmapheresis, Plateletpheresis Erythrocytapheresis, Leukoreduction/leukapheresis, Others (photopheresis, lipidpheresis, and Immunoadsoption) By Technology: Centrifugation and Membrane Separation/Filtration By Product type: Devices and Disposables By End-user: Blood banks/Blood collection centers, Hospitals & Hospital attached blood banks and Others The key players in the market are Haemonetics Corporation (U.S.), FRESENIUS MEDICAL CARE (Germany),& Terumo BCT, Inc. (U.S.), Asahi Kasei Medical Co., Ltd. (Japan), Kawasumi Laboratories Inc (Japan), and HemaCare Corporation (U.S.), with Haemonetics leading the pack. |
Upcoming |
|
|
Asian Apheresis Market The Asian Apheresis market was valued at $353.79 million in 2013 and is expected to reach $467.59 million by 2018 growing at a CAGR of 13.0% from 2013 to 2018. Apheresis market can be segmented by By Procedure: Donor Apheresis and Therapeutic Apheresis (Neurologic Disorders, Blood Disorders (TTP, Leukemia, & Others), Renal Disease , Metabolic Disorders, Others (Rheumatic disorders, Malaria, Hyperviscosity syndrome, & others) By Application: (Plasmapheresis, Plateletpheresis Erythrocytapheresis, Leukoreduction/leukapheresis, Others (photopheresis, lipidpheresis, and Immunoadsoption) By Technology: Centrifugation and Membrane Separation/Filtration By Product type: Devices and Disposables By End-user: Blood banks/Blood collection centers, Hospitals & Hospital attached blood banks and Others The key players in the market are Haemonetics Corporation (U.S.), FRESENIUS MEDICAL CARE (Germany),& Terumo BCT, Inc. (U.S.), Asahi Kasei Medical Co., Ltd. (Japan), Kawasumi Laboratories Inc (Japan), and HemaCare Corporation (U.S.), with Haemonetics leading the pack. |
Upcoming |
